Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort
Arturo Ciccullo(San Salvatore Hospital), Simona Di Giambenedetto(Università Cattolica del Sacro Cuore), Gaetana Sterrantino(University of Florence), Andrea Giacomelli(ASST Fatebenefratelli Sacco), Massimiliano Fabbiani(University of Siena), Alessandra Latini(San Gallicano Hospital), Paolo Fusco(Magna Graecia University), Gabriella d’Ettorre(Policlinico Umberto I), Vanni Borghi(University of Modena and Reggio Emilia), Letizia Oreni(Washington University in St. Louis), Gianmaria Baldin(Agostino Gemelli University Polyclinic), Giordano Madeddu(University of Sassari), Cristina Mussini(University of Modena and Reggio Emilia), Alessandro Grimaldi(San Salvatore Hospital), Filippo Lagi(Policlinico Umberto I), Amedeo Capetti(Luigi Sacco Hospital)
Cited by 12
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272